Unbiased AI-powered news
Researchers used the two drugs to lower metabolism and body temperature in large animals. The combination proved safe in a phase one clinical trial. @ScienceMagazine reported the results.
gizmodo.comResearchers used chlorpromazine and promethazine to induce hypothermia that lowered metabolism and body temperature in large animals, protecting them from stroke, @ScienceMagazine reported. The same drug combination was tested in a phase one clinical trial that established its safety. The approach relies on the two approved medications to trigger a controlled drop in body temperature.
This state reduces metabolic demand during periods when blood flow to the brain is interrupted. @ScienceMagazine reported that the phase one trial focused solely on safety and did not assess efficacy against stroke in humans.
StatThe outbreak in Ituri province, declared May 15, has killed 254 people and infected 1,003. Contact tracing covers only 55 percent of known exposures amid rebel violence that blocks access to villages.
financialexpress.comAbbVie will pay $10.9 billion in cash to buy Apogee Therapeutics, a Waltham-based developer of immunology drugs. The deal values Apogee shares at $135.11 each, a roughly 50 percent premium to the prior close.
The IndependentRecord spring rains and snowmelt flooded northern Michigan homes, exposing gaps in federal flood maps and insurance access for thousands of residents. Many property owners had been told they were outside mapped flood zones and could not obtain coverage.